NAS10030,482+2.83%S&P7,765+1.49%GOLD$4,355−0.66%BTC$85,266VIX14.87+0.41%live tape · as of 11:00 UTC
The Screen · Basic Materials · Specialty Chemicals
Sensient Technologies Corporation
SXT · the NYSE · USD · Market cap $5.5B · 4,070 employees
Sensient Technologies Corporation, together with its subsidiaries, manufactures and markets colors, flavors, and other specialty ingredients worldwide.
Positioning no disclosures inside 60 days, left as found
Options no verdict drawn today, left as found
Ethical passes the values gate
Price129.65 USD
Fair value90.95
Ethical score70.0/100
Our investment reviews on this name
2026-09-14Read Accumulation128.60+0.8% to today ✓
2026-08-14Read Markup128.50+0.9% to today ✓
2026-07-02Read Distribution124.11+4.5% to today
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Sensient Technologies Corporation holds its Markdown at $129.65. The statistical read favours the sellers, held for 3 days.
As held on the ledger · 2026-09-21
Phase
Markdown · caution
Quantitative state
The statistical read favours the sellers, held for 3 days
Price at the screen
$129.65
Valuation
34.95 trailing · 26.14 forward price to earnings
Values screen
PASS· score 70.0
Beta
0.78
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
31.62%
Below 33%
Interest-bearing debt is just 31.6% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
15.24%
Below 49%
Money owed to the company is 15.2% of assets, under the 49% limit.
Pass
Revenue purity
0.00%
Below 5%
Only 0.0% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
Fair value range in USD, drawn from the 2026-09-21 screen. The gold marker is the market price at the same screen. The price runs 29.8% above the base estimate.
Third-party analyst targets: 5 covering, consensus None. The average target sits +8% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-21 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Flavours and colours maker priced for perfection
Walk into any supermarket and the bright hues in snacks or drinks often trace back to specialty chemical makers like Sensient. The business delivers solid 11% revenue growth and clears a 9% profit margin, yet our fair value sits at 89.37 dollars against a 109.05 dollar share price. That negative margin of safety rules out any opportunity, even though the ethical screen clears.
A forward multiple of 23 times earnings looks rich once the cyclical nature of specialty chemicals is factored in. Peak demand for flavours and extracts can flatten quickly when consumer spending slows, and a 12% return on equity offers little cushion if volumes turn. Analyst targets above 139 dollars ignore how low multiples at the top of a cycle often signal the start of mean reversion rather than a bargain.
Risks centre on raw material swings and customer concentration in food and beverage markets, both of which can compress margins faster than growth can offset. The absence of a clear moat leaves little protection when the cycle shifts. Analysis, not advice.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
SXT trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 0.1% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 26%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (4 analysts) rates it buy, with a mean price target of $133.
2026-08-14Markup · changed$128.50+3.5%Entry 4
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 3.5% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 26%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (4 analysts) rates it buy, with a mean price target of $133.
2026-07-18Distribution$124.11+0.0%Entry 3
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 26%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (4 analysts) rates it buy, with a mean price target of $133.
2026-07-03Distribution$124.11+0.0%Entry 2
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.
2026-07-02Distribution$124.11Entry 1
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
